Search research articles
Contact Us
Filters
Showing results (11-20 of 86) with videos related to
Page
of 9
Sort By:
Current Opinion in Rheumatology
|
May 3, 2001
Combination therapy in rheumatoid arthritis
Y P Goekoop, C F Allaart, F C Breedveld, et al.
Scandinavian Journal of Rheumatology
|
June 6, 2014
Comparison of characteristics of international and national databases for rheumatoid arthritis: a systematic literature review
E Gvozdenović, R Koevoets, J Langenhoff, et al.
Scandinavian Journal of Rheumatology
|
July 14, 2022
Presence of SARS-CoV-2 antibodies in patients with COVID-19 like symptoms from the IENIMINI cohort
L van Ouwerkerk, D van der Woude, T Rispens, et al.
BMJ (Clinical Research Ed.)
|
October 7, 1995
Survival in families with hereditary protein C deficiency, 1820 to 1993
C F Allaart, F R Rosendaal, W M Noteboom, et al.
Blood
|
August 15, 1991
The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: heterogeneity and founder effects
P H Reitsma, S R Poort, C F Allaart, et al.
Annals of the Rheumatic Diseases
|
June 8, 2013
Drug therapy in undifferentiated arthritis: a systematic literature review
K V C Wevers-de Boer, L Heimans, T W J Huizinga, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 28, 2004
Cavitating pneumonia after treatment with infliximab and prednisone
S M Arend, E J Kuijper, C F Allaart, et al.
Clinical and Experimental Rheumatology
|
February 19, 2004
The Leiden Early Arthritis Clinic
J van Aken, J H van Bilsen, C F Allaart, et al.
Lancet (London, England)
|
January 16, 1993
Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect
C F Allaart, S R Poort, F R Rosendaal, et al.
Seminars in Arthritis and Rheumatism
|
November 22, 2023
Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world data analysis
L van Ouwerkerk, S A Bergstra, T D Maarseveen, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 86) with videos related to
Sort By:
Page
of 9
Current Opinion in Rheumatology
|
May 3, 2001
Combination therapy in rheumatoid arthritis
Y P Goekoop, C F Allaart, F C Breedveld, et al.
Scandinavian Journal of Rheumatology
|
June 6, 2014
Comparison of characteristics of international and national databases for rheumatoid arthritis: a systematic literature review
E Gvozdenović, R Koevoets, J Langenhoff, et al.
Scandinavian Journal of Rheumatology
|
July 14, 2022
Presence of SARS-CoV-2 antibodies in patients with COVID-19 like symptoms from the IENIMINI cohort
L van Ouwerkerk, D van der Woude, T Rispens, et al.
BMJ (Clinical Research Ed.)
|
October 7, 1995
Survival in families with hereditary protein C deficiency, 1820 to 1993
C F Allaart, F R Rosendaal, W M Noteboom, et al.
Blood
|
August 15, 1991
The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: heterogeneity and founder effects
P H Reitsma, S R Poort, C F Allaart, et al.
Annals of the Rheumatic Diseases
|
June 8, 2013
Drug therapy in undifferentiated arthritis: a systematic literature review
K V C Wevers-de Boer, L Heimans, T W J Huizinga, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 28, 2004
Cavitating pneumonia after treatment with infliximab and prednisone
S M Arend, E J Kuijper, C F Allaart, et al.
Clinical and Experimental Rheumatology
|
February 19, 2004
The Leiden Early Arthritis Clinic
J van Aken, J H van Bilsen, C F Allaart, et al.
Lancet (London, England)
|
January 16, 1993
Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect
C F Allaart, S R Poort, F R Rosendaal, et al.
Seminars in Arthritis and Rheumatism
|
November 22, 2023
Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world data analysis
L van Ouwerkerk, S A Bergstra, T D Maarseveen, et al.
Page
of 9